February 7, 2012
Pharmacy news, jobs, continuing education, community and more.
Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. With the introduction of XIENCE PRIME in the United States, Abbott, the worldwide leader in drug eluting stent technology, now offers physicians an [...]
Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has granted approval for the use of ALIMTA® (pemetrexed for injection) as a single agent for continuation maintenance therapy in patients with a particular type of lung cancer, called advanced nonsquamous non-small cell lung cancer (NSCLC). The approval is based on clinical trial [...]
Responding to the growing diabetes and obesity epidemic in the United States, Abbott (NYSE: ABT) is introducing Glucerna® Hunger Smart(TM) nutrition shakes and bars for people with diabetes. Diabetes affects more than 25 million Americans, according to the Centers for Disease Control and Prevention. If the current trend continues, one in three Americans will develop [...]
Pfizer Inc. (NYSE: PFE) announced today that the European Commission has approved the Company’s pneumococcal conjugate vaccine, Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), for active immunization for the prevention of vaccine-type invasive disease caused by Streptococcus pneumoniae in adults aged 50 years and older. “Prevenar 13, the first and only pneumococcal conjugate vaccine [...]
NEW YORK – Pfizer Inc. (NYSE: PFE) and the National Association of Boards of Pharmacy® (NABP) are launching a new effort to draw attention to the risks associated with counterfeit prescription medicines and help patients learn how to safely buy medicines online. Prescription medicines are among the most counterfeited consumer goods. Worldwide sales of counterfeit [...]
Orem, Utah – Oncology is an extremely complex discipline. Part of that complexity results from physicians moving between hospitals and clinics, patients moving between infusion suites and radiation oncology facilities, and medical records not being always immediately at hand. The new KLAS report Oncology IS 2011: Integrating the Island shares study results of oncology best-of-breed [...]
Livonia, MI — GenScripts Pharmacy, a pharmacy catered exclusively to self-pay patients in Tulsa, Oklahoma, increases prescription filling speed and enhances customer service with the Eyecon® tabletop automation solution by Avery Weigh-Tronix. With its Visual Counting System™, the Eyecon provides users with an efficient, high-accuracy prescription validation, counting and filling solution. The system is designed [...]
PRINCETON, N.J. -Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) formulation of ORENCIA® (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis (RA). ORENCIA is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural [...]
INDIANAPOLIS – Eli Lilly and Company (NYSE:LLY) today announced that the U.S. Court of Appeals for the Federal Circuit has overturned a prior ruling by the U.S. District Court for the District of New Jersey and has upheld the validity of the company’s method-of-use patent on Strattera® (atomoxetine). In the case of Eli Lilly and [...]
NEW DELHI and MUMBAI, India, – Eli Lilly India (Lilly) and Lupin Limited (Lupin)today announced they have entered into a strategic collaboration to promote and distribute Lilly’s Huminsulin range of products, including Huminsulin R(TM), Huminsulin NPH(TM), Huminsulin 50/50(TM), Huminsulin 30/70(TM) and Humapen Ergo II. Lupin’s India formulations business will promote and distribute the range of [...]
© Rx Times, LLC 2011. All rights reserved. All products denoted with ™ and ® are trademarks or registered trademarks of Rx Times, LLC and/or its affiliates.